Molecular interaction fingerprint approaches for GPCR drug discovery.

Protein-ligand interaction fingerprints (IFPs) are binary 1D representations of the 3D structure of protein-ligand complexes encoding the presence or absence of specific interactions between the binding pocket amino acids and the ligand. Various implementations of IFPs have been developed and successfully applied for post-processing molecular docking results for G Protein-Coupled Receptor (GPCR) ligand binding mode prediction and virtual ligand screening. Novel interaction fingerprint methods enable structural chemogenomics and polypharmacology predictions by complementing the increasing amount of GPCR structural data. Machine learning methods are increasingly used to derive relationships between bioactivity data and fingerprint descriptors of chemical and structural information of binding sites, ligands, and protein-ligand interactions. Factors that influence the application of IFPs include structure preparation, binding site definition, fingerprint similarity assessment, and data processing and these factors pose challenges as well possibilities to optimize interaction fingerprint methods for GPCR drug discovery.

[1]  J. Wess,et al.  Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.

[2]  Dmitri B. Kireev,et al.  Structural Protein–Ligand Interaction Fingerprints (SPLIF) for Structure-Based Virtual Screening: Method and Benchmark Study , 2014, J. Chem. Inf. Model..

[3]  Gilles Marcou,et al.  Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints , 2007, J. Chem. Inf. Model..

[4]  Screening of phytochemicals against protease activated receptor 1 (PAR1), a promising target for cancer , 2015, Journal of receptor and signal transduction research.

[5]  Didier Rognan,et al.  sc-PDB: a 3D-database of ligandable binding sites—10 years on , 2014, Nucleic Acids Res..

[6]  Takatsugu Hirokawa,et al.  Extended Template-Based Modeling and Evaluation Method Using Consensus of Binding Mode of GPCRs for Virtual Screening , 2014, J. Chem. Inf. Model..

[7]  George Papadatos,et al.  The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..

[8]  Adrià Cereto-Massagué,et al.  Molecular fingerprint similarity search in virtual screening. , 2015, Methods.

[9]  Christofer S Tautermann,et al.  GPCR structures in drug design, emerging opportunities with new structures. , 2014, Bioorganic & medicinal chemistry letters.

[10]  Didier Rognan,et al.  Encoding Protein-Ligand Interaction Patterns in Fingerprints and Graphs , 2013, J. Chem. Inf. Model..

[11]  Saskia Nijmeijer,et al.  Structure-based virtual screening for fragment-like ligands of the G protein-coupled histamine H4 receptor , 2015 .

[12]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[13]  Bas Vroling,et al.  GPCRdb: an information system for G protein-coupled receptors , 2015, Nucleic Acids Res..

[14]  Chris de Graaf,et al.  KLIFS: a structural kinase-ligand interaction database , 2015, Nucleic Acids Res..

[15]  Didier Rognan,et al.  sc-PDB-Frag: A Database of Protein-Ligand Interaction Patterns for Bioisosteric Replacements , 2014, J. Chem. Inf. Model..

[16]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[17]  Saskia Nijmeijer,et al.  Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT3A, Histamine H1, and Histamine H4 Receptors , 2015, J. Chem. Inf. Model..

[18]  Didier Rognan,et al.  Computational Profiling of Bioactive Compounds Using a Target-Dependent Composite Workflow , 2013, J. Chem. Inf. Model..

[19]  Chris de Graaf,et al.  Generic GPCR residue numbers - aligning topology maps while minding the gaps. , 2015, Trends in pharmacological sciences.

[20]  Gabriele Cruciani,et al.  A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application , 2007, J. Chem. Inf. Model..

[21]  Georgi K. Kanev,et al.  PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design. , 2016, Journal of medicinal chemistry.

[22]  Saskia Nijmeijer,et al.  Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular Fingerprints , 2012, J. Chem. Inf. Model..

[23]  Chris de Graaf,et al.  Function-specific virtual screening for GPCR ligands using a combined scoring method , 2016, Scientific Reports.

[24]  Chris de Graaf,et al.  From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands. , 2013, Methods in enzymology.

[25]  Chris de Graaf,et al.  Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study , 2015, J. Chem. Inf. Model..

[26]  Andrzej J. Bojarski,et al.  Multi-Step Protocol for Automatic Evaluation of Docking Results Based on Machine Learning Methods - A Case Study of Serotonin Receptors 5-HT6 and 5-HT7 , 2015, J. Chem. Inf. Model..

[27]  Tina Ritschel,et al.  Pharmacophore Fingerprint-Based Approach to Binding Site Subpocket Similarity and Its Application to Bioisostere Replacement , 2012, J. Chem. Inf. Model..

[28]  S. P. Andrews,et al.  Extra-helical binding site of a glucagon receptor antagonist , 2016, Nature.

[29]  Tom L. Blundell,et al.  CREDO: a structural interactomics database for drug discovery , 2013, Database J. Biol. Databases Curation.

[30]  Ruben Abagyan,et al.  Pocketome: an encyclopedia of small-molecule binding sites in 4D , 2011, Nucleic Acids Res..

[31]  Antonio Lavecchia,et al.  Machine-learning approaches in drug discovery: methods and applications. , 2015, Drug discovery today.

[32]  Z. Deng,et al.  Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. , 2004, Journal of medicinal chemistry.

[33]  R. Leurs,et al.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design , 2013, British journal of pharmacology.

[34]  Didier Rognan,et al.  Structure‐Based Discovery of Allosteric Modulators of Two Related Class B G‐Protein‐Coupled Receptors , 2011, ChemMedChem.

[35]  Ingebrigt Sylte,et al.  Protein binding site analysis by means of structural interaction fingerprint patterns. , 2011, Bioorganic & medicinal chemistry letters.

[36]  Hualiang Jiang,et al.  Two disparate ligand-binding sites in the human P2Y1 receptor , 2015, Nature.

[37]  Chris de Graaf,et al.  A Molecular Pharmacologist’s Guide to G Protein–Coupled Receptor Crystallography , 2015, Molecular Pharmacology.

[38]  Hugo Gutiérrez-de-Terán,et al.  Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonists , 2012, Journal of Computer-Aided Molecular Design.

[39]  Yanli Wang,et al.  Predicting Molecular Targets for Small‐Molecule Drugs with a Ligand‐Based Interaction Fingerprint Approach , 2016, ChemMedChem.

[40]  R. Stevens,et al.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor. , 2011, Journal of medicinal chemistry.

[41]  Igor I. Baskin,et al.  Predicting Ligand Binding Modes from Neural Networks Trained on Protein-Ligand Interaction Fingerprints , 2013, J. Chem. Inf. Model..

[42]  Saskia Nijmeijer,et al.  Small and colorful stones make beautiful mosaics: fragment-based chemogenomics. , 2013, Drug Discovery Today.

[43]  David E. Gloriam,et al.  Chemogenomics of allosteric binding sites in GPCRs. , 2013, Drug discovery today. Technologies.